FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111194055> ?p ?o ?g. }

• W2111194055 endingPage "1588" @default.
• W2111194055 startingPage "1584" @default.
• W2111194055 abstract "The effects of cefodizime and cefuroxime on neutrophil phagocytosis and reactive oxygen production in 54 patients undergoing elective coronary artery bypass grafting were studied. Both drugs were administered twice at a dosage of 40 mg/kg of body weight (pre- and intraoperative). Phagocytic capacity was assessed by measuring the uptake of fluorescein isothiocyanate-labeled Escherichia coli and Staphylococcus aureus by flow cytometry. Reactive oxygen generation after phagocytosis was estimated by determining the amount of dihydrorhodamine 123 converted to rhodamine 123 intracellularly. In both groups the mean phagocytic ability for E. coli and S. aureus decreased during surgery (-21 and -8%, respectively, for the cefodizime group and -39 and -38%, respectively, for the cefuroxime group; P < 0.05 for all). In the cefodizime group a normalization of mean E. coli and S. aureus neutrophil phagocytosis was seen on day 5 (+9 and -4% compared to preoperative values; P > 0.35 for both), whereas in cefuroxime-treated patients phagocytic ability remained depressed (-37 and -31%; P < 0.04 for both). In both groups mean neutrophil reactive oxygen intermediate (ROI) production after E. coli and S. aureus phagocytosis increased during cardiopulmonary bypass (+44 and +83%, respectively, in the cefodizime group and +58 and +73%, respectively, in the cefuroxime group; P < 0.05 for all). One day after surgery E. coli- and S. aureus-driven neutrophil ROI production was not different from the preoperative values (-2 and +12%, respectively, for the cefodizime group and +7 and +15%, respectively, for the cefuroxime group; P > 0.15 for all). Postoperative serum levels of the C-reactive protein on days 2 and 7 were lower in cefodizime-treated patients (19 +/- 6 and 4 +/- 2 mg/liter versus 23 +/- 6 and 11 +/- 5 mg/liter; P < 0.05 for both). In addition to cefodizime's antimicrobial activity during perioperative prophylaxis, its use in coronary artery bypass grafting can prevent procedure-related prolonged postoperative neutrophil phagocytosis impairment." @default.
• W2111194055 created "2016-06-24" @default.
• W2111194055 creator A5023471727 @default.
• W2111194055 creator A5027634511 @default.
• W2111194055 creator A5053064074 @default.
• W2111194055 creator A5056791346 @default.
• W2111194055 creator A5056909352 @default.
• W2111194055 creator A5057954263 @default.
• W2111194055 creator A5077495526 @default.
• W2111194055 date "1997-07-01" @default.
• W2111194055 modified "2023-09-26" @default.
• W2111194055 title "Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting" @default.
• W2111194055 cites W106670602 @default.
• W2111194055 cites W175418708 @default.
• W2111194055 cites W1934775191 @default.
• W2111194055 cites W1976378044 @default.
• W2111194055 cites W1980389623 @default.
• W2111194055 cites W1984028474 @default.
• W2111194055 cites W1987507388 @default.
• W2111194055 cites W1988305225 @default.
• W2111194055 cites W1990253794 @default.
• W2111194055 cites W1997192444 @default.
• W2111194055 cites W2020162180 @default.
• W2111194055 cites W2024059762 @default.
• W2111194055 cites W2025206857 @default.
• W2111194055 cites W2031010994 @default.
• W2111194055 cites W2033928915 @default.
• W2111194055 cites W2037533927 @default.
• W2111194055 cites W2048656459 @default.
• W2111194055 cites W2051409358 @default.
• W2111194055 cites W2052361044 @default.
• W2111194055 cites W2061416346 @default.
• W2111194055 cites W2067663745 @default.
• W2111194055 cites W2071162264 @default.
• W2111194055 cites W2080135923 @default.
• W2111194055 cites W2086046576 @default.
• W2111194055 cites W2086728546 @default.
• W2111194055 cites W2090977835 @default.
• W2111194055 cites W2100022455 @default.
• W2111194055 cites W2133660310 @default.
• W2111194055 cites W2140198409 @default.
• W2111194055 cites W2167905237 @default.
• W2111194055 cites W2229437028 @default.
• W2111194055 cites W2323434906 @default.
• W2111194055 cites W2330568965 @default.
• W2111194055 cites W2341630418 @default.
• W2111194055 cites W2409689696 @default.
• W2111194055 cites W2415485550 @default.
• W2111194055 cites W37581298 @default.
• W2111194055 cites W4252692016 @default.
• W2111194055 cites W76514550 @default.
• W2111194055 doi "https://doi.org/10.1128/aac.41.7.1584" @default.
• W2111194055 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/163964" @default.
• W2111194055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9210690" @default.
• W2111194055 hasPublicationYear "1997" @default.
• W2111194055 type Work @default.
• W2111194055 sameAs 2111194055 @default.
• W2111194055 citedByCount "9" @default.
• W2111194055 countsByYear W21111940552019 @default.
• W2111194055 countsByYear W21111940552023 @default.
• W2111194055 crossrefType "journal-article" @default.
• W2111194055 hasAuthorship W2111194055A5023471727 @default.
• W2111194055 hasAuthorship W2111194055A5027634511 @default.
• W2111194055 hasAuthorship W2111194055A5053064074 @default.
• W2111194055 hasAuthorship W2111194055A5056791346 @default.
• W2111194055 hasAuthorship W2111194055A5056909352 @default.
• W2111194055 hasAuthorship W2111194055A5057954263 @default.
• W2111194055 hasAuthorship W2111194055A5077495526 @default.
• W2111194055 hasBestOaLocation W21111940551 @default.
• W2111194055 hasConcept C126322002 @default.
• W2111194055 hasConcept C141071460 @default.
• W2111194055 hasConcept C160448771 @default.
• W2111194055 hasConcept C203014093 @default.
• W2111194055 hasConcept C2777514703 @default.
• W2111194055 hasConcept C2779489039 @default.
• W2111194055 hasConcept C42219234 @default.
• W2111194055 hasConcept C501593827 @default.
• W2111194055 hasConcept C523546767 @default.
• W2111194055 hasConcept C54355233 @default.
• W2111194055 hasConcept C71924100 @default.
• W2111194055 hasConcept C86803240 @default.
• W2111194055 hasConcept C89423630 @default.
• W2111194055 hasConcept C90924648 @default.
• W2111194055 hasConceptScore W2111194055C126322002 @default.
• W2111194055 hasConceptScore W2111194055C141071460 @default.
• W2111194055 hasConceptScore W2111194055C160448771 @default.
• W2111194055 hasConceptScore W2111194055C203014093 @default.
• W2111194055 hasConceptScore W2111194055C2777514703 @default.
• W2111194055 hasConceptScore W2111194055C2779489039 @default.
• W2111194055 hasConceptScore W2111194055C42219234 @default.
• W2111194055 hasConceptScore W2111194055C501593827 @default.
• W2111194055 hasConceptScore W2111194055C523546767 @default.
• W2111194055 hasConceptScore W2111194055C54355233 @default.
• W2111194055 hasConceptScore W2111194055C71924100 @default.
• W2111194055 hasConceptScore W2111194055C86803240 @default.
• W2111194055 hasConceptScore W2111194055C89423630 @default.
• W2111194055 hasConceptScore W2111194055C90924648 @default.
• W2111194055 hasIssue "7" @default.

• next